A new player in the puzzle of filovirus entry

Nature Reviews Microbiology

Volumn 10, Issue 5, 2012, Pages 317-322

  White, Judith M ^a   Schornberg, Kathryn L ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN; HOST FACTOR; NIEMANN PICK C1 PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

EBOLA VIRUS; FILOVIRUS; HEMORRHAGIC FEVER; HOST CELL; MARBURG VIRUS; NONHUMAN; PRIMATE; PRIORITY JOURNAL; PROTEIN BINDING; REVIEW; VIRUS ENTRY;

CARRIER PROTEINS; EBOLAVIRUS; HUMANS; MEMBRANE GLYCOPROTEINS; MODELS, BIOLOGICAL; MODELS, MOLECULAR; RECEPTORS, VIRUS; VIRAL ENVELOPE PROTEINS; VIRUS INTERNALIZATION;

EBOLA VIRUS; MARBURGVIRUS; PRIMATES;

EID: 84859897771     PISSN: 17401526     EISSN: 17401534     Source Type: Journal    
DOI: 10.1038/nrmicro2764     Document Type: Review

References (60)

1. Feldmann, H. & Geisbert, T. W. Ebola haemorrhagic fever. Lancet 377, 849-862 (2011).
2. Sullivan, N. J., Martin, J. E., Graham, B. S. & Nabel, G. J. Correlates of protective immunity for Ebola vaccines: implications for regulatory approval by the animal rule. Nature Rev. Microbiol. 7, 393-400 (2009).
3. Kuhn, J. H. et al. Proposal for a revised taxonomy of the family Filoviridae: classification, names of taxa and viruses, and virus abbreviations. Arch. Virol. 155, 2083-2103 (2010).
4. Borio, L. et al. Hemorrhagic fever viruses as biological weapons: medical and public health management. JAMA 287, 2391-2405 (2002).
5. Miranda, M. E. & Miranda, N. L. Reston ebolavirus in humans and animals in the Philippines: a review. J. Infect. Dis. 204 (Suppl. 3), S757-S760 (2011).
6. Negredo, A. et al. Discovery of an ebolavirus-like filovirus in Europe. PLoS Pathog. 7, e1002304 (2011).
7. Dube, D. et al. Cell adhesion-dependent membrane trafficking of a binding partner for the ebolavirus glycoprotein is a determinant of viral entry. Proc. Natl Acad. Sci. USA 107, 16637-16642 (2010).
8. Backovic, M. & Rey, F. Virus entry: old viruses, new receptors. Curr. Opin. Virol. 2, 4-13 (2012).
9. Matsuno, K. et al. C-type lectins do not act as functional receptors for filovirus entry into cells. Biochem. Biophys. Res. Commun. 403, 144-148 (2010).
10. Alvarez, C. P. et al. C-type lectins DC-SIGN and L-SIGN mediate cellular entry by Ebola virus in cis and in trans. J. Virol. 76, 6841-6844 (2002).
11. Simmons, G. et al. DC-SIGN and DC-SIGNR bind ebola glycoproteins and enhance infection of macrophages and endothelial cells. Virology 305, 115-123 (2003).
12. Takada, A. et al. Human macrophage C-type lectin specific for galactose and N-acetylgalactosamine promotes filovirus entry. J. Virol. 78, 2943-2947 (2004).
13. 1,2): sequence and residues critical for host cell binding. J. Virol. 83, 2883-2891 (2009).
14. Kondratowicz, A. S. et al. T-cell immunoglobulin and mucin domain 1 (TIM-1) is a receptor for Zaire Ebolavirus and Lake Victoria Marburgvirus. Proc. Natl Acad. Sci. USA 108, 8426-8431 (2011).
15. Lee, J. E. & Saphire, E. O. Ebolavirus glycoprotein structure and mechanism of entry. Future Virol. 4, 621-635 (2009).
16. Shimojima, M., Ikeda, Y. & Kawaoka, Y. The mechanism of Axl-mediated Ebola virus infection. J. Infect. Dis. 196 (Suppl. 2), S259-S263 (2007).
17. Takada, A. et al. Downregulation of β1 integrins by Ebola virus glycoprotein: implication for virus entry. Virology 278, 20-26 (2000).
18. Brindley, M. A. et al. Tyrosine kinase receptor Axl enhances entry of Zaire ebolavirus without direct interactions with the viral glycoprotein. Virology 415, 83-94 (2011).
19. 1-integrin controls ebolavirus entry by regulating endosomal cathepsins. Proc. Natl Acad. Sci. USA 106, 8003-8008 (2009).
20. Mulherkar, N., Raaben, M., de la Torre, J. C., Whelan, S. P. & Chandran, K. The Ebola virus glycoprotein mediates entry via a non-classical dynamin-dependent macropinocytic pathway. Virology 419, 72-83 (2011).
21. Nanbo, A. et al. Ebolavirus is internalized into host cells via macropinocytosis in a viral glycoprotein-dependent manner. PLoS Pathog. 6, e1001121 (2010).
22. Saeed, M. F., Kolokoltsov, A. A., Albrecht, T. & Davey, R. A. Cellular entry of Ebola virus involves uptake by a macropinocytosis-like mechanism and subsequent trafficking through early and late endosomes. PLoS Pathog. 6, e1001110 (2010).
23. Bharat, T. A. et al. Cryo-electron tomography of Marburg virus particles and their morphogenesis within infected cells. PLoS Biol. 9, e1001196 (2011).
24. Sanchez, A., Geisbert, T. & Feldmann, H. in Fields Virology (eds Knipe, D. & Howley, P.) 1407-1448 (Lippincott Williams and Wilkins, 2007).
25. Teissier, E., Penin, F. & Pecheur, E.-I. Targeting cell entry of enveloped viruses as an antiviral strategy. Molecules 16, 221-250 (2011).
26. Tilton, J. C. & Doms, R. W. Entry inhibitors in the treatment of HIV-1 infection. Antiviral Res. 85, 91-100 (2010).
27. Carette, J. E. et al. Ebola virus entry requires the cholesterol transporter Niemann-Pick C1. Nature 477, 340-343 (2011).
28. Cote, M. et al. Small molecule inhibitors reveal Niemann-Pick C1 is essential for Ebola virus infection. Nature 477, 344-348 (2011).
29. Miller, E. H. et al. Ebola virus entry requires the host-programmed recognition of an intracellular receptor. EMBO J. 6 Mar 2012 (doi:10.1038/emboj.2012.53).
30. Lee, J. E. et al. Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor. Nature 454, 177-182 (2008).
31. White, J. M., Delos, S. E., Brecher, M. & Schornberg, K. Structures and mechanisms of viral membrane fusion proteins: multiple variations on a common theme. Crit. Rev. Biochem. Mol. Biol. 43, 189-219 (2008).
32. Harrison, S. C. Viral membrane fusion. Nature Struct. Mol. Biol. 15, 690-698 (2008).
33. Wool-Lewis, R. J. & Bates, P. Endoproteolytic processing of the Ebola virus envelope glycoprotein: cleavage is not required for function. J. Virol. 73, 1419-1426 (1999).
34. Neumann, G. et al. Proteolytic processing of the Ebola virus glycoprotein is not critical for Ebola virus replication in nonhuman primates. J. Virol. 81, 2995-2998 (2007).
35. Chandran, K., Sullivan, N. J., Felbor, U., Whelan, S. P. & Cunningham, J. M. Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection. Science 308, 1643-1645 (2005).
36. Schornberg, K. et al. Role of endosomal cathepsins in entry mediated by the Ebola virus glycoprotein. J. Virol. 80, 4174-4178 (2006).
37. Hood, C. L. et al. Biochemical and structural characterization of cathepsin L-processed Ebola virus glycoprotein: implications for viral entry and immunogenicity. J. Virol. 84, 2972-2982 (2010).
38. Dias, J. M. et al. A shared structural solution for neutralizing ebolaviruses. Nature Struct. Mol. Biol. 18, 1424-1427 (2011).
39. Kuhn, J. H. et al. Conserved receptor-binding domains of Lake Victoria marburgvirus and Zaire ebolavirus bind a common receptor. J. Biol. Chem. 281, 15951-15958 (2006).
40. Manicassamy, B., Wang, J., Jiang, H. & Rong, L. Comprehensive analysis of Ebola virus GP1 in viral entry. J. Virol. 79, 4793-4805 (2005).
41. Brindley, M. A. et al. Ebola virus glycoprotein 1: identification of residues important for binding and postbinding events. J. Virol. 81, 7702-7709 (2007).
42. Mpanju, O. M., Towner, J. S., Dover, J. E., Nichol, S. T. & Wilson, C. A. Identification of two amino acid residues on Ebola virus glycoprotein 1 critical for cell entry. Virus Res. 121, 205-214 (2006).
43. Wong, A. C., Sandesara, R. G., Mulherkar, N., Whelan, S. P. & Chandran, K. A forward genetic strategy reveals destabilizing mutations in the Ebolavirus glycoprotein that alter its protease dependence during cell entry. J. Virol. 84, 163-175 (2010).
44. Brecher, M. et al. Cathepsin cleavage potentiates the Ebola virus glycoprotein to undergo a subsequent fusion relevant conformational change. J. Virol. 86, 364-372 (2012).
45. Kaletsky, R. L., Simmons, G. & Bates, P. Proteolysis of the Ebola glycoproteins enhances virus binding and infectivity. J. Virol. 81, 13378-13384 (2007).
46. Gregory, S. M. et al. Structure and function of the complete internal fusion loop from Ebolavirus glycoprotein 2. Proc. Natl Acad. Sci. USA 108, 11211-11216 (2011).
47. Carette, J. E. et al. Haploid genetic screens in human cells identify host factors used by pathogens. Science 326, 1231-1235 (2009).
48. Epp, N., Rethmeier, R., Kramer, L. & Ungermann, C. Membrane dynamics and fusion at late endosomes and vacuoles - Rab regulation, multisubunit tethering complexes and SNAREs. Eur. J. Cell Biol. 90, 779-785 (2011).
49. Huotari, J. & Helenius, A. Endosome maturation. EMBO J. 30, 3481-3500 (2011).
50. Pryor, P. R. & Luzio, J. P. Delivery of endocytosed membrane proteins to the lysosome. Biochim. Biophys. Acta 1793, 615-624 (2009).
51. Frolov, A. et al. Cholesterol overload promotes morphogenesis of a Niemann-Pick C (NPC)-like compartment independent of inhibition of NPC1 or HE1/NPC2 function. J. Biol. Chem. 276, 46414-46421 (2001).
52. Lloyd-Evans, E. & Platt, F. M. Lipids on trial: the search for the offending metabolite in Niemann-Pick type C disease. Traffic 11, 419-428 (2010).
53. Kobayashi, T. et al. Late endosomal membranes rich in lysobisphosphatidic acid regulate cholesterol transport. Nature Cell Biol. 1, 113-118 (1999).
54. Vitner, E. B., Platt, F. M. & Futerman, A. H. Common and uncommon pathogenic cascades in lysosomal storage diseases. J. Biol. Chem. 285, 20423-20427 (2010).
55. Deffieu, M. S. & Pfeffer, S. R. Niemann-Pick type C 1 function requires lumenal domain residues that mediate cholesterol-dependent NPC2 binding. Proc. Natl Acad. Sci. USA 108, 18932-18936 (2011).
56. Lozach, P.-Y., Huotari, J. & Helenius, A. Late-penetrating viruses. Curr. Opin. Virol. 1, 35-43 (2011).
57. Lloyd-Evans, E. et al. Niemann-Pick disease type C1 is a sphingosine storage disease that causes deregulation of lysosomal calcium. Nature Med. 14, 1247-1255 (2008).
58. Liu, R., Lu, P., Chu, J. W. & Sharom, F. J. Characterization of fluorescent sterol binding to purified human NPC1. J. Biol. Chem. 284, 1840-1852 (2009).
59. Ko, D. C., Gordon, M. D., Jin, J. Y. & Scott, M. P. Dynamic movements of organelles containing Niemann-Pick C1 protein: NPC1 involvement in late endocytic events. Mol. Biol. Cell 12, 601-614 (2001).
60. Sobo, K. et al. Late endosomal cholesterol accumulation leads to impaired intra-endosomal trafficking. PLoS ONE 2, e851 (2007).